Literature DB >> 7315858

Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients.

S Bansal, L A Lee, P D Woolf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7315858     DOI： 10.1016/0002-9343(81)90314-4

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

Review 1.  Hyperprolactinemia: neuroendocrine and diagnostic aspects.

Authors:  F Camanni; E Ciccarelli; E Ghigo; E E Müller
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

2.  More on nomifensine.

Authors:  A Liuzzi; P G Chiodini
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

3.  Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.

Authors:  E Ghigo; E Ciccarelli; A Novelli; M Massobrio; E E Müller; F Camanni
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

4.  Prolactin-secreting pituitary adenomas.

Authors:  M C Martin; E D Schriock; R B Jaffe
Journal:  West J Med       Date:  1983-11

5.  Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.

Authors:  D Dallabonzana; A Liuzzi; G Oppizzi; G Verde; P G Chiodini; R Dorow; R Horowski
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.